PTP1B inhibitors as potential therapeutics in the treatment of Type 2 diabetes and obesity

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.2, 2003-02, pp. : 223-233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein-Tyrosine Phosphatase 1B (PTP1B): A Novel Therapeutic Target for Type 2 Diabetes Mellitus, Obesity and Related States of Insulin Resistance

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 1, Iss. 3, 2001-11 ,pp. : 265-275

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Inhibition of Protein Tyrosine Phosphatase 1B: A Promising Strategy for the Treatment of Obesity and Type 2 Diabetes Mellitus

Current Medicinal Chemistry, Vol. 20, Iss. 21, 2013-01 ,pp. : 2609-2625

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Protein Tyrosine Phosphatase 1B as a Potential Treatment of Diabetes and Obesity

Current Pharmaceutical Design, Vol. 10, Iss. 28, 2004-11 ,pp. : 3481-3504

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes

By Drucker DJ

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 1, 2003-01 ,pp. : 87-100

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes

By Komers R. Komersova K.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2601-2617

Informa Healthcare

Access to resources Recommend Favorite